LMMY · Exousia Bio, Inc.
$0.02
+0.00 (+26.67%)
At close · Sep 2
Going-concern doubt
— flagged Jun 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. The Company has accumulated deficit from inception (January 31, 2022) to February 28, 2026, of $288,623. These factors among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.”View the 10-Q filed Jun 16, 2026
Market Cap
$944,999
Shares
52.50M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$3750
-67.4%
FY2025
Net Income
$51.4K
+299.2%
FY2025
Gross Margin
-93.36%
-109.3pp
FY2025
Diluted EPS
$0.00
FY2025
Operating Cash Flow
-$4528
+63.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $0 | $3750 | $11.5K | $0 | |
| $69.36K | $7251 | $9667 | $0 | |
| -$69.36K | -$3501 | $1833 | $0 | |
| — | -93.36% | 15.94% | — | |
| — | $28.38K | $28.08K | $56.42K | |
| $199.65K | $31.84K | $28.08K | $56.42K | |
| — | — | — | -$56.42K | |
| $131.41K | $86.74K | $436 | $0 | |
| -$137.6K | $51.4K | -$25.81K | -$56.42K | |
| $0 | $0 | $0 | $0 | |
| -$137.55K | $51.4K | -$25.81K | -$56.42K | |
| — | 1370.53% | -224.41% | — | |
| USD/shares | — | $0.00 | $0.00 | $0.00 |
| USD/shares | — | $0.00 | $0.00 | $0.00 |
| shares | — | 7.78M | 7.78M | 5.69M |
| shares | — | 7.78M | 7.78M | 5.69M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 15 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.